XBI · State Street
State Street SPDR S&P Biotech ETF
See how 149 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.
Core valuation
Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 99.88% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.
Largest reported holdings
| Holding | Weight | Trailing P/E | Trailing P/S |
|---|---|---|---|
| MRNAMODERNA INC | 2.85% | -23.94× | 33.86× |
| TWSTTWIST BIOSCIENCE CORP | 1.94% | -86.25× | 27.31× |
| ORKAORUKA THERAPEUTICS INC | 1.52% | -41.56× | Unavailable |
| APGEAPOGEE THERAPEUTICS INC | 1.47% | -34.62× | Unavailable |
| PRAXPRAXIS PRECISION MEDICINES I | 1.41% | -23.62× | Unavailable |
| HALOHALOZYME THERAPEUTICS INC | 1.38% | 29.35× | 7.30× |
| NTRANATERA INC | 1.38% | -306.11× | 21.75× |
| KYMRKYMERA THERAPEUTICS INC | 1.38% | -30.56× | 87.21× |
| PTGXPROTAGONIST THERAPEUTICS INC | 1.32% | 108.63× | 31.94× |
| DNTHDIANTHUS THERAPEUTICS INC | 1.31% | -25.70× | 2426.39× |
Top 10 of 149 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.
Most similar funds
Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.
- IBB · iShares Biotechnology ETF41.42% holdings overlap · US market
- FTXH · First Trust Nasdaq Pharmaceuticals ETF25.12% holdings overlap · Nasdaq
- PTH · Invesco Dorsey Wright Healthcare Momentum ETF24.84% holdings overlap · US market
- HELX · Franklin Genomic Advancements ETF22.03% holdings overlap · Cboe BZX
- BMED · iShares Health Innovation Active ETF20.78% holdings overlap · NYSE Arca
Sources and limitations
Holdings are sourced from State Street and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.
Open official holdings sourceResearch holdings date: 21 August 2026. Informational research, not investment advice.